Overview
Daniel Kakish is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. He has been practicing medicine for over 10 years.
His clinical expertise encompasses Cannabinoid Hyperemesis Syndrome (CHS).
He is actively involved in clinical research, co-authoring 2 peer reviewed articles.
Graduate Year
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE PART D
Locations
600 N Wolfe St, Baltimore, MD 21287
2500 Metrohealth Dr, Cleveland, OH 44109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Inova Medical Group - Transplant Specialties
Oksana A. Shlobin, MD, FCCP, serves as Medical Director for the Pulmonary Hypertension Program and Director of Outreach and Education for the Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital. She is also an Associate Professor of Clinical Medicine at Georgetown University School of Medicine and an Associate Clinical Professor of Medicine at the University of Virginia. Dr. Shlobin is board certified in pulmonary and critical care medicine. Dr. Shlobin has been actively involved in clinical research both during her fellowship and her tenure at Inova. She is co-author of multiple publications, including original research manuscripts, abstracts and book chapters. Her research interests include pulmonary hypertension and interstitial lung diseases. Blog Posts What is Pulmonary Hypertension? Learn the Facts to Breathe Easy (November 2018) Pulmonary Hypertension is Serious. Learn to Spot the Signs (May 2017). Dr. Shlobin is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Endoscopy.
University Of Maryland Dermatologists
Khanjan Nagarsheth is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Nagarsheth is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Arterial Embolism, Median Arcuate Ligament Syndrome (MALS), May Thurner Syndrome, Embolectomy, and Carotid Artery Surgery.
University Of Maryland Pediatric Associates PA
Thomas Scalea is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Scalea is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Necrotizing Fasciitis, Delirium, Low Blood Pressure, Fasciotomy, and Splenectomy.
Frequently Asked Questions about Dr. Daniel Kakish
How do I make an appointment with Dr. Daniel Kakish?
You can book an appointment with Dr. Daniel Kakish by calling their office at 410-955-9441. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Daniel Kakish a top-rated expert for Cannabinoid Hyperemesis Syndrome (CHS)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Daniel Kakish is classified as an Experienced expert for Cannabinoid Hyperemesis Syndrome (CHS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Daniel Kakish specialize in?
While Dr. Daniel Kakish is a Intensive Care Medicine, they have specific expertise in Cannabinoid Hyperemesis Syndrome (CHS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.
Does Dr. Daniel Kakish participate in research or clinical trials?
Yes. Dr. Daniel Kakish has published 2 articles and abstracts on conditions like Cannabinoid Hyperemesis Syndrome (CHS). You can view a list of Dr. Daniel Kakish's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Daniel Kakish accept my insurance?
Dr. Daniel Kakish accepts most major insurance plans, including Aetna and CareSource. We recommend calling the office directly at 410-955-9441 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cannabinoid Hyperemesis Syndrome (CHS)Dr. Kakish isExperienced. Learn about Cannabinoid Hyperemesis Syndrome (CHS).